Moreover, the tumorigenic CD44+/CD24neg/low side population of BCSCs derived from MCF7 and MDA-MB-231 breast cancer cells showed greater MSFE and were resistant to radiation when compared to the parental MCF7 and MDA-MB-231 breast cancer cells [200]. This evidence concerns the gene CD44 and breast cancer.